Wang Xiaohui 4

What Happened

• Wang Xiaohui, iQIYI's Chief Content Officer, was involved in derivative transactions on May 11, 2026 that show the cancellation/disposition of 1,531,250 and 7,500,000 prior awards and the simultaneous grant/acquisition of 1,531,250 and 7,500,000 new derivative awards (total 9,031,250). These are reported as derivative option-type awards (prices listed as N/A), not open-market stock sales or purchases. Per the filing footnotes, the reported actions include amendments that extend the options’ expiration date (as amended, options expire 10/18/2030).

Key Details

• Transaction date: 2026-05-11; Form 4 filed 2026-05-13 (appears timely within the usual 2-business-day window).
• Amounts: Dispositions of 1,531,250 and 7,500,000 prior derivative awards; corresponding grants/acquisitions of 1,531,250 and 7,500,000 new derivative awards (total 9,031,250).
• Price/Value: N/A on the Form 4 — these are option/derivative transactions, not open-market trades with a cash price.
• Vesting/terms (summary from footnotes): the 1,531,250 tranche is described as vesting over four years with 25% on the 1st anniversary of 05/11/2026 and the remaining 75% in 12 equal quarterly installments; the 7,500,000 tranche is described as vesting over four years with 25% vesting on each of the 1st–4th anniversaries of 05/11/2026. Footnotes also indicate some prior options were fully vested and that the amendments extended expiration dates to 10/18/2030.
• Shares owned after transaction: not specified in the provided summary of the filing.
• Filing timeliness: filed 2 days after the reported transactions; appears timely.

Context

• These filings reflect option/award amendments and regrants (derivative transactions), not immediate sales or purchases of common stock; no cash proceeds or open-market activity is shown. Option grants/amendments affect potential future dilution and executive compensation timelines but do not by themselves represent a buy or sell signal. For full legal and quantitative details (exact vesting language, exercise price, prior option terms), consult the complete Form 4 and its footnotes.